These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

404 related articles for article (PubMed ID: 26132109)

  • 1. Hurdles to clinical translation of human induced pluripotent stem cells.
    Neofytou E; O'Brien CG; Couture LA; Wu JC
    J Clin Invest; 2015 Jul; 125(7):2551-7. PubMed ID: 26132109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How far are induced pluripotent stem cells from the clinic?
    Li M; Chen M; Han W; Fu X
    Ageing Res Rev; 2010 Jul; 9(3):257-64. PubMed ID: 20362696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nuclear reprogramming and induced pluripotent stem cells: a review for surgeons.
    Qi SD; Smith PD; Choong PF
    ANZ J Surg; 2014 Jun; 84(6):417-23. PubMed ID: 24894037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Developing Induced Pluripotent Stem Cell-Based Therapy for the Masses.
    Rao MS; Atala A
    Stem Cells Transl Med; 2016 Feb; 5(2):129-31. PubMed ID: 26718646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of human allogeneic and syngeneic pluripotent stem cells and immunological implications for transplantation.
    Sackett SD; Brown ME; Tremmel DM; Ellis T; Burlingham WJ; Odorico JS
    Transplant Rev (Orlando); 2016 Apr; 30(2):61-70. PubMed ID: 26970668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of companion animal pluripotent stem cells.
    Paterson YZ; Kafarnik C; Guest DJ
    Cytometry A; 2018 Jan; 93(1):137-148. PubMed ID: 28678404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Key anticipated regulatory issues for clinical use of human induced pluripotent stem cells.
    Knoepfler PS
    Regen Med; 2012 Sep; 7(5):713-20. PubMed ID: 22830621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunogenicity of pluripotent stem cells and their derivatives.
    de Almeida PE; Ransohoff JD; Nahid A; Wu JC
    Circ Res; 2013 Feb; 112(3):549-61. PubMed ID: 23371903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nuclear reprogramming and induced pluripotent stem cells: a review for surgeons.
    Qi SD; Smith PD; Choong PF
    ANZ J Surg; 2014 Jun; 84(6):E1-11. PubMed ID: 23035845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonhuman primate models in translational regenerative medicine.
    Daadi MM; Barberi T; Shi Q; Lanford RE
    Stem Cells Dev; 2014 Dec; 23 Suppl 1(Suppl 1):83-7. PubMed ID: 25457970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospects and challenges of induced pluripotent stem cells as a source of hematopoietic stem cells.
    van Bekkum DW; Mikkers HM
    Ann N Y Acad Sci; 2012 Aug; 1266():179-88. PubMed ID: 22901269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enthusiasm for induced pluripotent stem cell-based therapies in kidney regeneration.
    Shen WC; Chou YH; Lin SL
    J Formos Med Assoc; 2016 Aug; 115(8):593-4. PubMed ID: 25043507
    [No Abstract]   [Full Text] [Related]  

  • 13. Human cord blood applications in cell therapy: looking back and look ahead.
    Zhou H; Chang S; Rao M
    Expert Opin Biol Ther; 2012 Aug; 12(8):1059-66. PubMed ID: 22681655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunogenicity of induced pluripotent stem cells.
    Okita K; Nagata N; Yamanaka S
    Circ Res; 2011 Sep; 109(7):720-1. PubMed ID: 21921270
    [No Abstract]   [Full Text] [Related]  

  • 15. "Mouse Clone Model" for evaluating the immunogenicity and tumorigenicity of pluripotent stem cells.
    Zhang G; Zhang Y
    Stem Cell Res Ther; 2015 Dec; 6():255. PubMed ID: 26687081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induced pluripotent stem (iPS) cells from human fetal stem cells.
    Guillot PV
    Best Pract Res Clin Obstet Gynaecol; 2016 Feb; 31():112-20. PubMed ID: 26427551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human stem cell research and regenerative medicine--present and future.
    Volarevic V; Ljujic B; Stojkovic P; Lukic A; Arsenijevic N; Stojkovic M
    Br Med Bull; 2011; 99():155-68. PubMed ID: 21669982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hope for regenerative treatments: toward safe transplantation of human pluripotent stem-cell-based therapies.
    Kimbrel EA; Lanza R
    Regen Med; 2015; 10(2):99-102. PubMed ID: 25835474
    [No Abstract]   [Full Text] [Related]  

  • 19. Human pluripotent stem cells in regenerative medicine: where do we stand?
    Nguyen HT; Jacobs K; Spits C
    Reproduction; 2018 Oct; 156(5):R143-R153. PubMed ID: 30325181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current applications of human pluripotent stem cells: possibilities and challenges.
    Ho PJ; Yen ML; Yet SF; Yen BL
    Cell Transplant; 2012; 21(5):801-14. PubMed ID: 22449556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.